Sanofi Consumer Healthcare India Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q2 CY2026
- June 26, 2026
- Posted by: Kunal Singla
- Category: News
Sanofi Consumer Healthcare India Rs 3,736.50 (6 Oct 2026 close). 52-week range Rs 3,691.00 to Rs 5,255.00. Q2 CY2026 revenue Rs 235.7 cr, up 7%; profit Rs 68.8 cr.
Quick Answer
The Sanofi Consumer Healthcare India share price target for 2026 is Rs 3,456 to Rs 4,224, which is between 8 percent below and 13 percent above the last close of Rs 3,736.50, with bull and bear cases of Rs 5,100 to Rs 5,700 and Rs 2,310 to Rs 2,835. Sanofi Consumer Healthcare India reported Q2 CY2026 revenue up 7 percent to Rs 235.7 crore, profit before tax up 16 percent to Rs 91.9 crore and profit of Rs 68.8 crore against Rs 60.7 crore, helped by relaunches of Combiflam, Allegra and Depura. Domestic sales grew 12 percent while exports fell 9 percent on a high base, the first-half revenue rose 18 percent, and the stock trades at 32 times earnings against an industry average of 50 times. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.
The Sanofi Consumer Healthcare India share price target for 2026 is Rs 3,456 to Rs 4,224 in the Univest base case, with the stock at Rs 3,736.50 at the 6 October 2026 close. That is 28.9 percent below its 52-week high of Rs 5,255.00 and 1.2 percent above its 52-week low of Rs 3,691.00, and the stock moved down 19.8 percent over the past year. Sanofi Consumer Healthcare India was demerged from Sanofi India and sells Combiflam, Allegra and Depura. Debt to equity is 0.06 and the dividend yield is 2.01 percent. The stock trades on very thin volume.
Three things changed since the last update: Q2 CY2026 results on 28 July showed profit before tax up 16 percent, the stock has fallen in most weeks since early August, and it hit a 52-week low of Rs 3,691 in the week of 28 September. This Sanofi Consumer Healthcare India stock analysis covers the Sanofi Consumer Healthcare India share price today, the Sanofi Consumer Healthcare India share price target for 2026, 2027 and 2030, the Q2 CY2026 numbers, catalysts and risks, key price levels and a Sanofi Consumer Healthcare India buy or sell view.
Click Here – Get Free Investment Predictions
What Is the Sanofi Consumer Healthcare India Share Price Target for 2026?
The 2026 target for Sanofi Consumer Healthcare India shares is Rs 3,456 to Rs 4,224 in the Univest base case, which is -7.5% to +13.0% against the last close. The bull case is Rs 5,100 to Rs 5,700 and the bear case is Rs 2,310 to Rs 2,835. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.
Sanofi Consumer Healthcare India Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS | Target Multiple | Price Target (Rs) | Move vs Rs 3,736.50 |
|---|---|---|---|---|
| Bull Case | Rs 150 | 34x to 38x | 5,100 to 5,700 | +36.5% to +52.5% |
| Base Case | Rs 128 | 27x to 33x | 3,456 to 4,224 | -7.5% to +13.0% |
| Bear Case | Rs 105 | 22x to 27x | 2,310 to 2,835 | -38.2% to -24.1% |
FY28 EPS of Rs 128 in the base case compares with trailing EPS of Rs 115.50. The company reports on a calendar year, so FY28 here is the 12 months to March 2028, a blend of calendar 2027 and 2028, and the case assumes revenue growth near 10 percent with margin near 38 percent. Consumer healthcare names trade at 27 to 33 times earnings, and the stock trades at about 29 times the base estimate. The PE multiple used for each case is shown in the table, and the EPS estimate is a Univest assumption, not company guidance. Those assumptions set the Sanofi Consumer Healthcare India share price target range around the current price.
Sanofi Consumer Healthcare India Company Overview and Share Price Today as of 6 October 2026
Sanofi Consumer Healthcare India share price today is Rs 3,736.50 on the NSE at the 6 October 2026 close, before the market opens on 7 October. The market capitalisation is Rs 8,591 crore, and the stock trades at 32.3 times earnings against an industry average of 50 times. The Univest base case Sanofi Consumer Healthcare India share price target of Rs 3,456 to Rs 4,224 is -7.5% to +13.0% from here. The table below sets out the key numbers behind the Sanofi Consumer Healthcare India share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | SANOFICONR | BSE code 544250 |
| Sector | Consumer healthcare | Per Univest sector classification |
| Last Close (NSE) | Rs 3,736.50 | 6 Oct 2026 close |
| 52-Week High | Rs 5,255.00 | CMP is 28.9% below |
| 52-Week Low | Rs 3,691.00 | CMP is 1.2% above |
| 1-Year Return | About -20% | Weekly close Rs 4659.3 on 10 Oct 2025 to Rs 3736.5 |
| Market Capitalisation | Rs 8,591 crore | Small cap consumer healthcare company |
| Trailing P/E | About 32.3x | Industry P/E about 49.98x |
| P/B Ratio | About 24.69x | Book value Rs 151.07 per share |
| EPS (TTM) | Rs 115.50 | Trailing twelve months |
| Return on Equity | About 76.5% | Debt to equity 0.06 |
| Dividend Yield | About 2.01% | Dividend paid regularly |
| 12-Month Target (Base Case) | Rs 3,456 to Rs 4,224 | Univest base case |
| Bull Case | Rs 5,100 to Rs 5,700 | +36.5% to +52.5% |
| Bear Case | Rs 2,310 to Rs 2,835 | -38.2% to -24.1% |
How Did Sanofi Consumer Healthcare India Perform in Q2 CY2026?
Sanofi Consumer Healthcare India reported Q2 CY2026 revenue from operations of Rs 235.7 crore, up 7 percent, and profit before tax of Rs 91.9 crore, up 16 percent. Profit for the period was Rs 68.8 crore against Rs 60.7 crore, with EPS of Rs 29.87. Together these Q2 CY2026 numbers anchor the Sanofi Consumer Healthcare India share price target.
| Metric | Q2 CY2026 | Context |
|---|---|---|
| Revenue from Operations | Rs 235.7 crore | Up 7% YoY |
| Domestic Sales | Up 12% | Aided by brand relaunches |
| Export Sales | Down 9% | On a high base |
| Profit Before Tax | Rs 91.9 crore | Up 16% YoY |
| Profit for the Period | Rs 68.8 crore | Against Rs 60.7 crore |
| First-Half Revenue | Rs 464.9 crore | Up 18%; profit Rs 136.6 crore |
First-half domestic sales rose 14 percent and exports rose 27 percent on a low base. Operating margin is about 38 percent and first-half operating cash inflow was Rs 109.6 crore. The company attributed part of the gain to the relaunch of Combiflam, Allegra and Depura after a recall. The CY2026 and FY27 outlook from management is the main input for these estimates. These numbers sit behind every range in the scenario table above, so they anchor the Sanofi Consumer Healthcare India share price target.
Why Is Sanofi Consumer Healthcare India Share Price Down 29 Percent From Its High?
Sanofi Consumer Healthcare India shares are about 29 percent below the Rs 5,255 high of the week of 11 May 2026 and down 20 percent in a year. The stock jumped 11 percent in the week of 23 February on volume of 14 lakh shares against the usual 15,000, and rose 12 percent in the week of 30 March.
After a spike to Rs 4,927 in late July it fell in most weeks since early August, including 4 percent in the week of 28 September, to Rs 3,691. Trading is so thin, a few hundred shares a day at times, that prices can gap. The Sanofi Consumer Healthcare India share price target scenarios below account for that move.
Key Catalysts for the Sanofi Consumer Healthcare India Share Price Target in 2026
4 catalysts matter most for the Sanofi Consumer Healthcare India share price target, and sector tailwinds in Consumer healthcare are part of the case. Together they decide whether the base case is reached.
1. Brand Relaunches
Combiflam, Allegra and Depura were relaunched after a recall. Domestic sales grew 12 percent in Q2. If it plays out, the Sanofi Consumer Healthcare India share price target moves toward the top of the base range.
2. High Margin
Operating margin is about 38 percent. Strong brands keep profit per rupee of sales high. Strength here would support the upper end of the Sanofi Consumer Healthcare India share price target.
3. Export Recovery
First-half exports rose 27 percent on a low base. A steady recovery would add to growth. Delivery on this point keeps the Sanofi Consumer Healthcare India share price target on track.
4. Dividend and Cash
The yield is about 2 percent and debt to equity is 0.06. Strong cash flow supports payouts. Better news here would lift the Sanofi Consumer Healthcare India share price target toward the bull case.
What Are the Key Risks to the Sanofi Consumer Healthcare India Share Price Target?
The main risks are product recalls, thin trading, export swings and a high price to book. Each can pull the Sanofi Consumer Healthcare India share price target lower.
Product Recalls
The relaunches followed a recall. Another quality issue would hit sales and trust. If it materialises, the Sanofi Consumer Healthcare India share price target would slip toward the bear case.
Thin Trading
Volume can drop to a few hundred shares a day. Prices can gap on small orders. This is the main downside risk to the Sanofi Consumer Healthcare India share price target.
Export Swings
Exports fell 9 percent in Q2 on a high base. Export revenue moves quarter to quarter. A worsening here would cut the Sanofi Consumer Healthcare India share price target toward the low end of the range.
High Price to Book
The stock trades at 24.7 times book. A bear case EPS of Rs 105 at 22 times would put the price near Rs 2,310. Watch it closely, because it can pull the Sanofi Consumer Healthcare India share price target lower quickly.
Sanofi Consumer Healthcare India Stock Analysis: Support and Resistance Levels for the Share Price Target
Sanofi Consumer Healthcare India stock analysis on weekly charts shows a range of Rs 3,691 to Rs 4,112 since mid-September, with the stock near the lower end.
The first support level is Rs 3,691 to Rs 3,701, the lows of the weeks of 28 September and 5 October. Below that there is no weekly support, as Rs 3,691 is the 52-week low.
The first resistance level is Rs 3,788 to Rs 3,997.50, the highs of the weeks of 5 and 28 September. Above that, Rs 4,081 to Rs 4,112 marks the highs of the weeks of 21 and 14 September. These levels come from weekly price action, are not trade recommendations, and frame the near-term Sanofi Consumer Healthcare India share price target.
Sanofi Consumer Healthcare India Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term Sanofi Consumer Healthcare India Share Price Target (3 to 6 Months)
In the near term the stock is likely to trade between Rs 3,691 and Rs 3,997. A close above Rs 3,997 would put Rs 4,100 in play, while a weekly close under Rs 3,691 would open a fresh 52-week low. The Q3 CY2026 results are the main trigger. This range anchors the near-term Sanofi Consumer Healthcare India share price target.
12-Month and 2027 Sanofi Consumer Healthcare India Share Price Target
The 12-month target price is Rs 3,456 to Rs 4,224, valued on 27 to 33 times FY28 EPS of Rs 128. The range across scenarios runs from Rs 2,310 in the bear case to Rs 5,700 in the bull case.
Long-Term Sanofi Consumer Healthcare India Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 3,920 to Rs 5,214. This assumes EPS of Rs 140 in FY29 and Rs 158 in FY30 and a multiple of 28 to 33 times. It needs the Combiflam, Allegra and Depura relaunches to keep domestic growth near 12 percent and exports to recover. This is the long-term Sanofi Consumer Healthcare India share price target in the Univest scenarios.
Bull Case and Bear Case for Sanofi Consumer Healthcare India Share Price Target
Bull Case Rs 5,100 to Rs 5,700
The bull case of Rs 5,100 to Rs 5,700 for the Sanofi Consumer Healthcare India share price target needs EPS of Rs 150 and the market to pay 34 to 38 times for it. It is +36.5% to +52.5% from the last close.
Bear Case Rs 2,310 to Rs 2,835
The bear case of Rs 2,310 to Rs 2,835 for the Sanofi Consumer Healthcare India share price target equals 22 to 27 times FY28 EPS of Rs 105 and sits below the Rs 3691 low. It is -38.2% to -24.1% from the last close.
Is Sanofi Consumer Healthcare India a Good Buy at Rs 3,736? Sanofi Consumer Healthcare India Buy or Sell View
Whether Sanofi Consumer Healthcare India is a buy at Rs 3,736.50 depends on horizon and risk appetite. The base case sits between 8 percent below and 13 percent above the current price, the stock is 29 percent below its high, and the open question is whether the relaunch lifts sales further. The Sanofi Consumer Healthcare India share price target range is the starting point for that decision.
Long-term holders may focus on domestic growth, margin and exports, and treat Rs 3,691 as the level to watch. Short-term traders may prefer to wait for a close above Rs 3,997. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Sanofi Consumer Healthcare India buy or sell view is educational.
How to Invest in Sanofi Consumer Healthcare India Shares
Step 1: Check the live price, valuation and the latest Sanofi Consumer Healthcare India share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Sanofi Consumer Healthcare India share price target.
Step 3: Search for SANOFICONR on the NSE or 544250 on the BSE in your trading app.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 2,310 is bearable.
Step 5: Track domestic growth, exports and Q3 CY2026 results and set price alerts on the Univest App to follow any change in the Sanofi Consumer Healthcare India share price target.
Conclusion
Sanofi Consumer Healthcare India closed at Rs 3,736.50 against a Univest base case share price target of Rs 3,456 to Rs 4,224, a bull case of Rs 5,100 to Rs 5,700 and a bear case of Rs 2,310 to Rs 2,835. Q2 CY2026 delivered revenue growth of 7 percent and profit before tax growth of 16 percent. The main risks are product recalls, thin trading and export swings.
The stock is 28.9 percent below its 52-week high, so the base case sits between 8 percent below and 13 percent above the current price. The triggers to watch are domestic growth, exports and Q3 CY2026 results and the Rs 3,691 and Rs 3,997 levels. Re-check the Sanofi Consumer Healthcare India share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track Sanofi Consumer Healthcare India live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Sanofi Consumer Healthcare India Share Price Target 2026
What is the Sanofi Consumer Healthcare India share price target for 2026?
Ans. The Sanofi Consumer Healthcare India share price target for 2026 is Rs 3,456 to Rs 4,224 in the Univest base case, with a bull case of Rs 5,100 to Rs 5,700 and a bear case of Rs 2,310 to Rs 2,835. No brokerage target was available on the sources we track as of 6 October 2026, so these are Univest research scenarios. These are estimates and can change after the Q3 CY2026 results.
What is the Sanofi Consumer Healthcare India share price target for 2027?
Ans. The Sanofi Consumer Healthcare India share price target for 2027 is Rs 3,456 to Rs 4,224 in the base case, valued on 27 to 33 times FY28 EPS of Rs 128. The scenario range runs from Rs 2,310 to Rs 5,700.
Is Sanofi Consumer Healthcare India a good buy at Rs 3,736.50?
Ans. Whether Sanofi Consumer Healthcare India is a good buy at Rs 3,736.50 depends on your horizon, risk appetite and how you read the Sanofi Consumer Healthcare India share price target. Profit is growing and the multiple is below the industry, but trading is very thin and the stock sits at its 52-week low. Consult a SEBI-registered advisor before investing.
What are the key risks to the Sanofi Consumer Healthcare India share price target?
Ans. The key risks to the Sanofi Consumer Healthcare India share price target are product recalls, thin trading, export swings and high price to book. The relaunches followed a recall. Another quality issue would hit sales and trust.
What are the key catalysts for the Sanofi Consumer Healthcare India share price target?
Ans. The key catalysts for the Sanofi Consumer Healthcare India share price target are brand relaunches, high margin, export recovery and dividend and cash. Combiflam, Allegra and Depura were relaunched after a recall. Domestic sales grew 12 percent in Q2.
Where can I track Sanofi Consumer Healthcare India share price today and Sanofi Consumer Healthcare India share price target updates?
Ans. You can track the live Sanofi Consumer Healthcare India share price, results and any change to the Sanofi Consumer Healthcare India share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are Sanofi Consumer Healthcare India’s 52-week high and low?
Ans. Sanofi Consumer Healthcare India’s 52-week high is Rs 5,255.00 and its 52-week low is Rs 3,691.00, based on weekly NSE data. At Rs 3,736.50 the stock is 28.9 percent below the high and 1.2 percent above the low. Both levels frame the Sanofi Consumer Healthcare India share price target.
How to buy Sanofi Consumer Healthcare India shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for SANOFICONR on the NSE or 544250 on the BSE, and place a limit order near your entry price, using the Sanofi Consumer Healthcare India share price target range as a guide. Size the position so a fall to Rs 2,310 is bearable, and check the live price on the Univest Screener first.
